Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Deanna McLeod"'
Autor:
Anna V. Tinker, Neesha C. Dhani, Prafull Ghatage, Deanna McLeod, Vanessa Samouëlian, Stephen A. Welch, Alon D. Altman
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background and objectives: Endometrial cancer is a common malignancy and recurrences can be fatal. Although platinum-pretreated endometrial tumors are commonly treated with anthracyclines and taxanes, there is no current standard of care. Both immune
Externí odkaz:
https://doaj.org/article/39f2a9177c624dc4966f99714f895875
Autor:
Aly-Khan A. Lalani, Daniel Y. C. Heng, Naveen S. Basappa, Lori Wood, Nayyer Iqbal, Deanna McLeod, Denis Soulières, Christian Kollmannsberger
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: Renal cell carcinoma (RCC) is a common malignancy with approximately 30% of cases diagnosed at the advanced or metastatic stage. While single-agent vascular endothelial growth factor-targeted therapy has been a mainstay of treatment, data
Externí odkaz:
https://doaj.org/article/b4984d0e2fe74a72a65714b7537757fe
Autor:
Barbara Melosky, Parneet Cheema, Rosalyn A. Juergens, Natasha B. Leighl, Geoffrey Liu, Paul Wheatley-Price, Adrian Sacher, Stephanie Snow, Ming-Sound Tsao, Deanna McLeod, Quincy Chu
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of early-stage NSCLC and there is substantial clinical need
Externí odkaz:
https://doaj.org/article/b7c460474e584b6ca7677d4ff0d6ecf3
Autor:
Niel A. Karrow, Umesh K. Shandilya, Steven Pelech, Lauraine Wagter-Lesperance, Deanna McLeod, Byram Bridle, Bonnie A. Mallard
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1925 (2022)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/49133ff57a3c432e8add35df8e43feac
Autor:
Christine E. Simmons, Christine Brezden-Masley, Joy McCarthy, Deanna McLeod, Anil Abraham Joy
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Triple-negative breast cancer (TNBC) represents an aggressive breast cancer subtype with historically poor overall outcomes, due primarily to a lack of effective targeted agents. Chemotherapy has been the primary treatment approach, altho
Externí odkaz:
https://doaj.org/article/c02ec3ae4974448482723a7c335abbf2
Autor:
Niel A. Karrow, Umesh K. Shandilya, Steven Pelech, Lauraine Wagter-Lesperance, Deanna McLeod, Byram Bridle, Bonnie A. Mallard
Publikováno v:
Vaccines, Vol 9, Iss 11, p 1351 (2021)
Vaccines have been developed under accelerated timelines to combat the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus. Although they are considered the best approach for preventing mortality, when assessing the safety of these vaccines, pregn
Externí odkaz:
https://doaj.org/article/c303c08bfbcf41ad83864dfe0e2b9062
Autor:
Rebecca J. Deyell, Shantanu Banerji, Andrea J MacNeill, Alannah Smrke, Deanna McLeod, Francisco E. Vera-Badillo, Jonathan Noujaim, Albiruni Ryan Abdul Razak, Christine E. Simmons
Publikováno v:
International Journal of Cancer. 149:1691-1704
Malignant sarcomas are rare accounting for
Autor:
Michael Ong, Jean-Michel Lavoie, Nimira S. Alimohamed, Bernhard J. Eigl, Srikala S. Sridhar, Deanna McLeod, Scott North
Publikováno v:
The Oncologist
Background Metastatic urothelial carcinoma (mUC) historically is treated with first‐line platinum‐based combination chemotherapy, preferably cisplatin plus gemcitabine whenever possible. In recent years, multiple classes of targeted therapy have
Autor:
Brandon M Meyers, Jennifer J Knox, David M Liu, Deanna McLeod, Ravi Ramjeesingh, Vincent C Tam, Howard J Lim
Publikováno v:
Cancer Treatment Reviews. :102584
Autor:
Deanna McLeod, Paul Wheatley Price, Parneet Cheema, Rosalyn A. Juergens, Devin Schellenberg, Anthony Brade, Barbara Melosky, Quincy Chu, Geoffrey Liu, Kevin Jao, Natasha B. Leighl
Publikováno v:
Oncologist
BackgroundSmall cell lung cancer (SCLC) represents approximately 15% of lung cancers, and approximately 70% are diagnosed as extensive-stage SCLC (ES-SCLC). Although ES-SCLC is highly responsive to chemotherapy, patients typically progress rapidly, a